Kevin Hykes Appointed to CVRx Board of Directors

CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Kevin Hykes will join its Board of Directors effective December 21, 2022.

“We are excited to welcome an executive with the depth of expertise of Kevin Hykes to our Board of Directors,” said John Nehra, lead independent director of CVRx. “His commercial experience in accelerating the growth of novel interventional therapies and his executive acumen will prove an invaluable resource as we continue to build our business and increase access to Barostim™ for patients globally.”

“I am delighted that Kevin is joining our Board of Directors and know that he will provide exceptional guidance to our management team,” added Nadim Yared, President and CEO of CVRx. “Kevin’s proven track record in our field will bring tremendous value to CVRx as we accelerate commercial adoption of Barostim.”

Kevin Hykes is an accomplished medical device industry executive with 30 years’ experience commercializing novel therapies on a global basis. Kevin is currently the President and CEO of Augmedics, a pioneer in augmented reality surgical navigation. Prior to joining Augmedics, Kevin was President and CEO of Bardy Diagnostics, which was acquired by Hillrom in August of 2021. Before Bardy Diagnostics, Kevin was President and CEO of Relievant Medsystems, an Operating Partner at Versant Ventures, Chairman and CEO of Metavention, Inc., CEO of Cameron Health (Boston Scientific), and Chief Commercial Officer of Visiogen (Abbott). Prior to joining Visiogen, Kevin spent sixteen years at Medtronic in the CRM, Neurostimulation, and Cardiac Surgery businesses. Kevin is currently an Operating Partner with Revival Healthcare Capital and an independent board member at Metavention, Inc. Kevin received his MBA from Northwestern University and a BBA in Information Systems from the University of Wisconsin.

“I am honored to join the CVRx Board of Directors,” said Mr. Hykes. “I look forward to working with this excellent management team and to helping CVRx continue its momentum establishing Barostim as an important therapy for patients suffering from cardiovascular disease.”

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy